Syagen Technology Signs Agreement with Applied Biosystems/MDS SCIEX

Syagen Technology, Inc., announced that it has signed a cross licensing agreement with the joint venture of Applied Biosystems/MDS SCIEX, both analytical instrumentation businesses, to share patent claims covering atmospheric pressure photo-ionization (APPI) and methods of usage.

Syagen Technology, Inc., announced that it has signed a cross licensing agreement with the joint venture of Applied Biosystems/MDS SCIEX, both analytical instrumentation businesses, to share patent claims covering atmospheric pressure photo-ionization (APPI) and methods of usage. Syagen will supply the PhotoMate APPI source to the majority of the liquid chromatography/mass spectrometry (LC/MS) instrument manufacturers and Applied Biosystems/MDS SCIEX will supply the Photospray APPI source to customers of its LC/MS product line.

APPI is an important complement to electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI). It expands the range and classes of compounds that can be analyzed with LC/MS instruments, including nonpolar molecules, not easily ionized by either ESI or APCI, and by exhibiting less ion suppression than the other types of ionization sources.?We are very excited by this cross licensing agreement with Applied Biosystems/MDS SCIEX. The terms will allow our respective customers greater flexibility in maximizing the benefits of APPI,? says Dr. Jack A. Syage, CEO of Syagen.